Literature DB >> 2059554

Decorin interacts with fibrillar collagen of embryonic and adult human skin.

R Fleischmajer1, L W Fisher, E D MacDonald, L Jacobs, J S Perlish, J D Termine.   

Abstract

Biglycan (PG-I, BGN) and decorin (PG-II, DCN) are small proteoglycans that have been isolated in cartilage, skin, and bone. Although the function of biglycan is unknown, there is biochemical evidence that decorin interacts with fibrillar collagens (type I, type II). The purpose of this study was to perform immunofluorescence and immunoelectron microscopy and immunoblotting of human embryonic and adult skin with antibodies directed against biglycan and decorin. These antibodies were developed against synthetic peptides of the core proteins of biglycan (amino acid sequence 11-24) and decorin (amino acid sequence 5-17). Immunofluorescence microscopy showed that decorin stained embryonic and adult collagen fibrils. Biglycan did not stain collagen, but it appeared to stain the pericellular matrix of embryonic mesenchymal cells. Immunoelectron microscopy revealed labeling of all collagen fibrils with decorin antibodies regardless of their diameter, often at 60-nm periodicity. Positive stains suggest that most of the labeling was in the gap of the D-period (d and e bands) and also in one of the steps (c band). Decorin was identified by immunoblotting in fetal and adult skin. Also, significant amounts of core protein was identified lacking the dermatan sulfate chain. This study suggests that the core protein of decorin interacts with collagen fibrils although its specific function remains unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059554     DOI: 10.1016/1047-8477(91)90065-5

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  45 in total

Review 1.  The Ehlers-Danlos syndrome: on beyond collagens.

Authors:  J R Mao; J Bristow
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Age-related differences in human skin proteoglycans.

Authors:  David A Carrino; Anthony Calabro; Aniq B Darr; Maria T Dours-Zimmermann; John D Sandy; Dieter R Zimmermann; J Michael Sorrell; Vincent C Hascall; Arnold I Caplan
Journal:  Glycobiology       Date:  2010-10-14       Impact factor: 4.313

3.  Immunochemical analysis of human kidney reticulin.

Authors:  R Fleischmajer; L Jacobs; J S Perlish; B Katchen; E Schwartz; R Timpl
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

4.  Localisation of extracellular matrix components in the embryonic human notochord and axial mesenchyme.

Authors:  W Götz; R Osmers; R Herken
Journal:  J Anat       Date:  1995-02       Impact factor: 2.610

Review 5.  Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring.

Authors:  Meilang Xue; Christopher J Jackson
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

6.  Proteoglycans in Normal and Healing Skin.

Authors:  Margaret Mary Smith; James Melrose
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

7.  FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney.

Authors:  Jennifer L Fetting; Justin A Guay; Michele J Karolak; Renato V Iozzo; Derek C Adams; David E Maridas; Aaron C Brown; Leif Oxburgh
Journal:  Development       Date:  2013-11-27       Impact factor: 6.868

8.  A prospective study of the safety and efficacy of a combined bipolar radiofrequency, intense pulsed light, and infrared diode laser treatment for global facial photoaging.

Authors:  Min Jiang; Fang Yan; Mathew Avram; Zhong Lu
Journal:  Lasers Med Sci       Date:  2017-04-23       Impact factor: 3.161

9.  Collagen fibrillogenesis in a three-dimensional fibroblast cell culture system.

Authors:  P Contard; L Jacobs; J S Perlish; R Fleischmajer
Journal:  Cell Tissue Res       Date:  1993-09       Impact factor: 5.249

10.  Decorin core protein (decoron) shape complements collagen fibril surface structure and mediates its binding.

Authors:  Joseph P R O Orgel; Aya Eid; Olga Antipova; Jordi Bella; John E Scott
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.